Publications by authors named "S E Ottmann"

Background: Machine perfusion (MP) for liver transplantation has become more widespread in the United States, but national studies on this growing practice are lacking. We investigated national use and outcomes of MP for liver transplantation.

Methods: Adult (≥18 y) liver recipients transplanted between January 1, 2016 and September 30, 2023 in the United Network for Organ Sharing database were included.

View Article and Find Full Text PDF

Background: The project "Health for Everyone in the District" was implemented in Nuremberg from May 2017 to October 2022 as part of the law passed to strengthen health promotion and disease prevention with funding from Public Health Insurance, Bavaria. The aim was to implement health promotion measures through a decentralized system in four deprived parts of the city and thus promote health equity on site. Among other aspects, program loyalty, project scope, and acceptance, as well as continuity and establishment of permanent structures underwent external assessment.

View Article and Find Full Text PDF

Glucose uptake increases during B cell activation and antibody-secreting cell (ASC) differentiation, but conflicting findings prevent a clear metabolic profile at different stages of B cell activation. Deletion of the glucose transporter type 1 (GLUT1) gene in mature B cells (GLUT1-cKO) results in normal B cell development, but it reduces germinal center B cells and ASCs. GLUT1-cKO mice show decreased antigen-specific antibody titers after vaccination.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the effects of metastasis-directed therapy to all disease sites (MDT-All) in patients with recurrent hepatocellular carcinoma (HCC) who had limited disease after liver transplantation, defined as having 3 or fewer lesions (oligoM1).
  • Among 43 patients analyzed, 63% had oligoM1 disease, and those receiving MDT-All showed a significantly better overall survival rate compared to those who did not, with median survival of 38.4 months versus lower survival for non-MDT-All patients.
  • Key predictors of worse outcomes included microvascular invasion and high alpha-fetoprotein levels, while having oligoM1 was linked to more favorable survival
View Article and Find Full Text PDF